Academic Journal

The effectiveness of non-nucleoside dual therapy in 'naive' HIV patients

التفاصيل البيبلوغرافية
العنوان: The effectiveness of non-nucleoside dual therapy in 'naive' HIV patients
المؤلفون: Elena Veselova, Karina Kocharyan, Alla Peregudova, Valentina Tinkova, Anastasia Samoilova, Anastasiya Gaida
المصدر: Journal of Global Antimicrobial Resistance, Vol 39, Iss , Pp 4- (2024)
بيانات النشر: Elsevier, 2024.
سنة النشر: 2024
المجموعة: LCC:Microbiology
مصطلحات موضوعية: HIV infection, non-nucleoside dual therapy, efficacy, Microbiology, QR1-502
الوصف: INTRODUCTION: Non-nucleoside antiretroviral therapy (ART) regimens are used to reduce the risk of adverse events associated with the use of nucleoside reverse transcriptase inhibitors. One of these treatment regimens is dolutegravir, dovavirin (DTG, DOR) dual therapy. MATERIALS AND METHODS: The study included 152 ''naive''HIV patients no clinical manifestations, 79 received DTG, DOR (G1), 73 – DTG, tenofovir (TDF), emtricitabine (FTC) (G2). Viral load (VL) and immunological parameters (CD4+, CD8+, CD4+/CD8+ ratio) were determined in patients before the start of treatment, after 48 weeks of ART. The efficacy of treatment was determined by the average level of VL, the proportion of patients with undetectable VL and the proportion of patients with an increase in CD4+ more than 50 cl/µl. The assessment was carried out using t-test for independent samples, the differences were significant at p 0.05. RESULTS: Groups were comparable in age, gender, VL and immunological parameters (Table).48 weeks after the start of ART, average level of VL in G1 and G2 was 0.54 and 0.69 lg copies/ml, respectively (p =0.757). Undetectable VL in G1 was 92.4% of patients, in G2 – 90.4% of patients (p =0.882), increase in CD4+ more than 50 cl/µl in G1 was 98.7% of patients, in G2 – 98.6% (p=0.512) of patients. CONCLUSIONS: DTG, DOR dual therapy was comparable with DTG, TDF, FTC triple therapy: it allowed to achieve an undetectable VL in 92.4% of patients and an increase in CD4+ more than 50 cl/µl in 98.7% of patients after 48 weeks of ART.
نوع الوثيقة: article
وصف الملف: electronic resource
اللغة: English
تدمد: 2213-7165
Relation: http://www.sciencedirect.com/science/article/pii/S2213716524001875; https://doaj.org/toc/2213-7165
DOI: 10.1016/j.jgar.2024.10.010
URL الوصول: https://doaj.org/article/407a1d4718a442a495f5c8b0381b8b07
رقم الانضمام: edsdoj.407a1d4718a442a495f5c8b0381b8b07
قاعدة البيانات: Directory of Open Access Journals
الوصف
تدمد:22137165
DOI:10.1016/j.jgar.2024.10.010